Underuse of reperfusion therapy with systemic thrombolysis in high-risk acute pulmonary embolism in a Portuguese center
Revista Portuguesa de Cardiologia · 2024
DOI: 10.1016/j.repc.2023.07.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista Portuguesa de Cardiologia, 2024. Verfasst von Mariana Martinho und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital Garcia de Orta, Almada, Portugal. Electronic address: mariana.martinho6@gmail.com. Hauptthemen laut MEDLINE: Fibrinolysis, Pulmonary Embolism. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION: Reperfusion therapy is generally recommended in acute high-risk pulmonary embolism (HR-PE), but several population-based studies report that it is underused. Data on epidemiology, management and outcomes of HR-PE in Portugal are scarce. OBJECTIVE: To determine the reperfusion rate in HR-PE patients, the reasons for non-reperfusion, and how it influences outcomes. METHODS: In this retrospective cohort study of consecutive HR-PE patients admitted to a thromboembolic disease referral center between 2008 and 2018, independent predictors for non-reperfusion were assessed by multivariate logistic regression. PE-related mortality and long-term MACE (cardiovascular mortality, PE recurrence and chronic thromboembolic disease) were calculated according to the Kaplan-Meier method. Differences stratified by reperfusion were assessed using the log-rank test. RESULTS: Of 1955 acute PE patients, 3.8% presented with hemodynamic instability. The overall reperfusion rate was 50%: 35 patients underwent systemic thrombolysis, one received first-line percutaneous embolectomy and one rescue endovascular treatment. Independent predictors of non-reperfusion were: age, with >75 years representing 12 times the risk of non-treatment (OR 11.9, 95% CI 2.7-52.3, p=0.001); absolute contraindication for thrombolysis (31.1%), with recent major surgery and central nervous system disease as the most common reasons (OR 16.7, 95% CI 3.2-87.0, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Hospital Garcia de Orta, Almada, Portugal. Electronic address: mariana.martinho6@gmail.com.
- Cardiology Department, Hospital Garcia de Orta, Almada, Portugal.
- Internal Medicine Department, Hospital Garcia de Orta, Almada, Portugal.
- Intensive Care Unit, Hospital Garcia de Orta, Almada, Portugal.
- Cardiology Department, Hospital Garcia de Orta, Almada, Portugal; CCUL, CAML, Universidade de Lisboa, Lisboa, Portugal.
Zitieren
APA
Martinho, M., Calé, R., Grade Santos, J., Rita Pereira, A., Alegria, S., Ferreira, F., José Loureiro, M., Judas, T., Ferreira, M., Gomes, A., Morgado, G., Martins, C., Gonzalez, F., Lohmann, C., Delerue, F., & Pereira, H. (2024). Underuse of reperfusion therapy with systemic thrombolysis in high-risk acute pulmonary embolism in a Portuguese center. Revista Portuguesa de Cardiologia. https://doi.org/10.1016/j.repc.2023.07.005
Vancouver
Martinho M, Calé R, Grade Santos J, Rita Pereira A, Alegria S, Ferreira F, et al. Underuse of reperfusion therapy with systemic thrombolysis in high-risk acute pulmonary embolism in a Portuguese center. Revista Portuguesa de Cardiologia. 2024. doi:10.1016/j.repc.2023.07.005
BibTeX
@article{Martinho2024,
author = {Martinho, Mariana and Calé, Rita and Grade Santos, João and Rita Pereira, Ana and Alegria, Sofia and Ferreira, Filipa and José Loureiro, Maria and Judas, Tiago and Ferreira, Melanie and Gomes, Ana and Morgado, Gonçalo and Martins, Cristina and Gonzalez, Filipe and Lohmann, Corinna and Delerue, Francisca and Pereira, Hélder},
title = {Underuse of reperfusion therapy with systemic thrombolysis in high-risk acute pulmonary embolism in a Portuguese center},
journal = {Revista Portuguesa de Cardiologia},
year = {2024},
doi = {10.1016/j.repc.2023.07.005}
}
EUVIMED